Taiwanese study digs into DNA of rare stomach tumors to find new drug targets

NCT ID NCT04821895

First seen Jan 25, 2026 · Last updated May 15, 2026 · Updated 11 times

Summary

This study looks at the genetic makeup of a rare stomach cancer called GIST in 50 Taiwanese patients whose tumors lack the most common gene changes. By analyzing their DNA, researchers hope to find new treatment options for these hard-to-treat cases. The goal is to better understand the disease and improve future care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTROINTESTINAL STROMAL TUMOR (GIST) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Chang Gung Memorial Hospital

    Kaohsiung City, Taiwan

  • Chang Gung Memorial Hospital

    Taoyuan, Taiwan

  • China Medical University Hospital

    Taichung, Taiwan

  • Kaohsiung Medical University Chung-Ho Memorial Hospital

    Kaohsiung City, Taiwan

  • Kaohsiung Veterans General Hospital

    Kaohsiung City, Taiwan

  • Mackay Memorial Hospital

    Taipei, Taiwan

  • National Cheng Kung University Hospital

    Tainan, Taiwan

  • National Taiwan University Hospital

    Taipei, Taiwan

  • Taichung Veterans General Hospital

    Taichung, Taiwan

  • Taipei Veterans General Hospital

    Taipei, Taiwan

  • Tri-Service General Hospital

    Taipei, Taiwan

Conditions

Explore the condition pages connected to this study.